Nearly 12,000 drug treatment programs around the country will benefit from years of drug abuse and addiction research thanks to the NIDA Clinical Toolbox: Science-Based Materials for Drug Abuse Counselors. The toolbox, packaged in a bright gray box with a large "TX" on the front, will be available later this month from the National Institute on Drug Abuse (NIDA). The online version is available now.
Medical researchers meeting in Toronto this week called for a vaccination program to combat the increasing incidence of pertussis (whooping cough) among adolescents and adults. While there is zero mortality from pertussis in
adolescents and adults, those who have or are in contact with young children
should be immunized in an attempt to protect infants, who do suffer morbidity and mortality. The discussion took place at the American Society for Microbiology's 40th annual conference on antimicrobial agents and chemotherapy. This issue of Vidyya has additional background information, for health professionals, about pertusis from the CDC.
Medicine is controversy. The Canadian National Breast Screening Study-2
(CNBSS-2) published Thursday in the Journal of the National Cancer Institute
may be flawed because it is based on poor quality mammograms that were done
before the introduction of specific training and quality accreditation in
mammography and because of the basic design of the study. According to the Canadian Association of Radiologists, the CNBSS-2 falsely
concludes that adding mammography for breast cancer screening to physical
examinations does not reduce deaths.
In another controversial issue, the Food and Drug Administration (FDA) is set to decide the fate of mifepristone -- formerly known as RU-486, the French abortion pill -- by 30 September 2000. This political "hot potato" is an issue we're sure to hear more about over the coming week.
The articles in today's Vidyya are:
As always, we hope you enjoy the issue.